nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—ADRB2—polycystic ovary syndrome	0.846	1	CbGaD
Carteolol—Nadolol—ADRB3—polycystic ovary syndrome	0.00187	0.152	CrCbGaD
Carteolol—Bupranolol—ADRB3—polycystic ovary syndrome	0.00179	0.145	CrCbGaD
Carteolol—Bopindolol—ADRB3—polycystic ovary syndrome	0.00171	0.139	CrCbGaD
Carteolol—Pindolol—ADRB3—polycystic ovary syndrome	0.00118	0.0955	CrCbGaD
Carteolol—Levobunolol—ADRB2—polycystic ovary syndrome	0.000939	0.0762	CrCbGaD
Carteolol—Nadolol—ADRB2—polycystic ovary syndrome	0.000712	0.0577	CrCbGaD
Carteolol—Bupranolol—ADRB2—polycystic ovary syndrome	0.000679	0.0551	CrCbGaD
Carteolol—Bopindolol—ADRB2—polycystic ovary syndrome	0.000651	0.0528	CrCbGaD
Carteolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000642	0.0521	CrCbGaD
Carteolol—Salbutamol—ADRB2—polycystic ovary syndrome	0.000638	0.0518	CrCbGaD
Carteolol—Penbutolol—ADRB2—polycystic ovary syndrome	0.000621	0.0504	CrCbGaD
Carteolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000448	0.0363	CrCbGaD
Carteolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000244	0.0198	CrCbGaD
Carteolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000209	0.017	CrCbGaD
Carteolol—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000194	0.00137	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000191	0.00135	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000189	0.00134	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000187	0.00132	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000185	0.00131	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000184	0.00131	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000183	0.00129	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000182	0.00129	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000181	0.00128	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00018	0.00128	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000178	0.00126	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000178	0.00126	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000178	0.00126	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000177	0.00126	CbGpPWpGaD
Carteolol—ADRB1—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000177	0.00126	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000177	0.00125	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000174	0.00123	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000174	0.00123	CbGpPWpGaD
Carteolol—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000173	0.00123	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000173	0.00122	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000171	0.00121	CbGpPWpGaD
Carteolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000169	0.00119	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000169	0.00119	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000168	0.00119	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000167	0.00119	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000167	0.00119	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000165	0.00117	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000165	0.00117	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000164	0.00116	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000164	0.00116	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000164	0.00116	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000161	0.00114	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00016	0.00113	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000158	0.00112	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000157	0.00111	CbGpPWpGaD
Carteolol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000155	0.0011	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000153	0.00108	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000152	0.00108	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000152	0.00108	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000152	0.00108	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000151	0.00107	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000149	0.00106	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000149	0.00105	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000149	0.00105	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000149	0.00105	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000148	0.00105	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000145	0.00102	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000142	0.00101	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000141	0.000997	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000141	0.000995	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000139	0.000985	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000139	0.000981	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000138	0.000977	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000135	0.000958	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000135	0.000956	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000135	0.000952	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000134	0.000951	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000132	0.000932	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000131	0.00093	CbGpPWpGaD
Carteolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000126	0.000891	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000125	0.000882	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000123	0.000872	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000123	0.000868	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000122	0.000865	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000122	0.000862	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00012	0.000853	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00012	0.000849	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00012	0.000846	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000112	0.000793	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000111	0.000788	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000111	0.000787	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00011	0.000777	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00011	0.000776	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000109	0.000771	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000108	0.000764	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000108	0.000762	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000107	0.000755	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000106	0.000747	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000105	0.000745	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000104	0.000738	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000104	0.000738	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000103	0.00073	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000102	0.000722	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000102	0.000721	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.99e-05	0.000707	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.96e-05	0.000705	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.8e-05	0.000694	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.77e-05	0.000692	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.73e-05	0.000689	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	9.68e-05	0.000685	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.58e-05	0.000678	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.56e-05	0.000677	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.53e-05	0.000675	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.52e-05	0.000674	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	9.47e-05	0.00067	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.46e-05	0.00067	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.35e-05	0.000662	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.32e-05	0.00066	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.26e-05	0.000655	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	9.07e-05	0.000642	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.98e-05	0.000636	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.98e-05	0.000636	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.97e-05	0.000635	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	8.87e-05	0.000628	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.84e-05	0.000626	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.79e-05	0.000622	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.79e-05	0.000622	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.66e-05	0.000613	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.47e-05	0.000599	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.45e-05	0.000598	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.4e-05	0.000595	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.27e-05	0.000585	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.22e-05	0.000582	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	8.16e-05	0.000577	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.98e-05	0.000565	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.93e-05	0.000562	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	7.89e-05	0.000558	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.76e-05	0.000549	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	7.73e-05	0.000547	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	7.56e-05	0.000535	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.22e-05	0.000511	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	7.21e-05	0.000511	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	7.21e-05	0.000511	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.06e-05	0.0005	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	7.04e-05	0.000498	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.89e-05	0.000487	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	6.71e-05	0.000475	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	6.69e-05	0.000473	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	6.57e-05	0.000465	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	6.44e-05	0.000456	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	6.43e-05	0.000455	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.39e-05	0.000452	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	6.3e-05	0.000446	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.25e-05	0.000443	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.18e-05	0.000438	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.05e-05	0.000428	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	6.01e-05	0.000426	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.88e-05	0.000416	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	5.86e-05	0.000415	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.83e-05	0.000412	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.79e-05	0.00041	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	5.73e-05	0.000406	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	5.72e-05	0.000405	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	5.7e-05	0.000404	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	5.7e-05	0.000404	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.66e-05	0.000401	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	5.59e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.59e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.47e-05	0.000387	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.41e-05	0.000383	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.4e-05	0.000382	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	5.36e-05	0.000379	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.3e-05	0.000375	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	5.29e-05	0.000375	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.29e-05	0.000374	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	5.24e-05	0.000371	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.11e-05	0.000362	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	5.02e-05	0.000356	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5e-05	0.000354	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.98e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.92e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.91e-05	0.000347	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.87e-05	0.000345	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.8e-05	0.00034	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	4.78e-05	0.000338	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	4.65e-05	0.000329	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	4.59e-05	0.000325	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.55e-05	0.000322	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	4.53e-05	0.000321	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.49e-05	0.000318	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	4.39e-05	0.000311	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	4.32e-05	0.000306	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	4.29e-05	0.000304	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.17e-05	0.000295	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.1e-05	0.00029	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.08e-05	0.000289	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	4.06e-05	0.000288	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.01e-05	0.000284	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.97e-05	0.000281	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	3.85e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.78e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.78e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.69e-05	0.000261	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.69e-05	0.000261	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	3.67e-05	0.00026	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.64e-05	0.000257	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.6e-05	0.000255	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.56e-05	0.000252	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.52e-05	0.000249	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.51e-05	0.000249	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.5e-05	0.000248	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.44e-05	0.000243	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.42e-05	0.000242	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	3.35e-05	0.000237	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	3.32e-05	0.000235	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	3.3e-05	0.000234	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	3.29e-05	0.000233	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	3.28e-05	0.000232	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.25e-05	0.00023	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.23e-05	0.000229	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	3.22e-05	0.000228	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.18e-05	0.000225	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	3.17e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.13e-05	0.000221	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.11e-05	0.00022	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.92e-05	0.000207	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.9e-05	0.000205	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.84e-05	0.000201	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.83e-05	0.0002	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.76e-05	0.000195	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.73e-05	0.000193	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.71e-05	0.000192	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.7e-05	0.000191	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.65e-05	0.000188	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.62e-05	0.000185	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.59e-05	0.000183	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.44e-05	0.000173	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.4e-05	0.00017	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.32e-05	0.000164	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	2.27e-05	0.000161	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.27e-05	0.000161	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.22e-05	0.000157	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	2.08e-05	0.000147	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.03e-05	0.000143	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2.02e-05	0.000143	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.98e-05	0.00014	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.95e-05	0.000138	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.94e-05	0.000137	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.91e-05	0.000135	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.9e-05	0.000135	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.9e-05	0.000134	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.88e-05	0.000133	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.88e-05	0.000133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.84e-05	0.00013	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.83e-05	0.00013	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.78e-05	0.000126	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.74e-05	0.000123	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.7e-05	0.00012	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.62e-05	0.000114	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.53e-05	0.000109	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.44e-05	0.000102	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.43e-05	0.000101	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.4e-05	9.94e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.23e-05	8.68e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.2e-05	8.49e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.16e-05	8.21e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.14e-05	8.09e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.14e-05	8.05e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	8.48e-06	6e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	8.3e-06	5.87e-05	CbGpPWpGaD
